Your session is about to expire
← Back to Search
Protein Supplement
bovine lactoferrin supplement for Immune Health
N/A
Waitlist Available
Research Sponsored by Mead Johnson Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 45, day 90, day 180, day 270, and day 365
Awards & highlights
Study Summary
This trial tests if bLf can reduce respiratory infections in the elderly. Double-blind and placebo-controlled.
Eligible Conditions
- Immune Health
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 45, day 90, day 180, day 270, and day 365
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 45, day 90, day 180, day 270, and day 365
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Body Weight
COVID Vaccine specific inflammatory panel
Complete Blood Count
+18 moreSide effects data
From 2018 Phase 2 trial • 55 Patients • NCT018305952%
Hospitalized for syncope episode
2%
Cough, congestion, sinus pressure, fatigue
2%
Bone spur on spine
2%
surgery on rotator cuff
2%
torn rotator cuff
2%
Depression
2%
Elevated CK
2%
Bone
2%
Fatigue, cough and sore throat
2%
tinnitus
2%
right leg pain
2%
Upper Respiratory infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
Recombinant Lactoferrin
Placebo
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Investigational: 600 mg bovine lactoferrin supplementExperimental Treatment1 Intervention
Investigational: 600 mg bovine lactoferrin supplement
Group II: Control: PlaceboPlacebo Group1 Intervention
Control: Placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
bovine lactoferrin supplement
2021
N/A
~90
Find a Location
Who is running the clinical trial?
Mead Johnson NutritionLead Sponsor
79 Previous Clinical Trials
16,292 Total Patients Enrolled
Steven Wu, MDStudy DirectorMead Johnson/RB
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment phase of this trial ongoing?
"Unfortunately, this medical trial is not accepting patients at the present time. The first post of this study was launched on February 8th 2021 and underwent its last update in March 10th 2023. Even though recruitment for this clinical trial has concluded, there are still 94 other studies actively looking for qualified respondents."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger